Cerebral Bloodflow and Carbondioxide Reactivity During Mild Therapeutic Hypothermia in Patients After Cardiac Arrest
NCT ID: NCT00441753
Last Updated: 2009-02-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
10 participants
OBSERVATIONAL
2006-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Duration of Hypothermia for Neuroprotection After Pediatric Cardiac Arrest
NCT00797680
Effects of Hypothermia Upon Outcomes After Acute Traumatic Brain Injury
NCT00178711
Normothermia in Patients With Acute Cerebral Damage
NCT00491192
Head Computed Tomography for Predicting Neurological Outcome After Cardiac Arrest
NCT03913065
Targeted Temperature Management After Intracerebral Hemorrhage
NCT01866384
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* GCS after return of circulation \< 7
* Induced mild hypothermia for 24 hours
* primary rhythm ventricular fibrillation
Exclusion Criteria
* Cardiogenic shock with expected survival \< 24 hrs
* Pregnancy
* No informed consent
18 Years
95 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Radboud University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Radboud UNiversity Nijmegen Medical Centre
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cornelia Hoedemaekers, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Radboud University Medical Center
Johannes van der Hoeven, MD PhD
Role: STUDY_DIRECTOR
Radboud University Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Radboud University Nijmegen Medical Centre
Nijmegen, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KSCH0601
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.